Abstract:Background Encephalopathy is a common complication of sepsis, and its onset can occur at any stage of sepsis and implies worse prognosis. However, the incidence, epidemiology, and pathogenesis of sepsis-associated encephalopathy remain controversial. The purpose of this study was to investigate the epidemiological features and risk factors for sepsis-associated encephalopathy.Methods Our retrospective study included all patients with sepsis admitted to our intensive care unit from 2008 to 2011. After excluding 91 patients, 232 patients were assigned to either a sepsis-associated encephalopathy group or sepsis without encephalopathy group. Between-group differences in baseline patient data including vital signs, disease severity, pathogens, sites of infection, biochemical indicators, and time on a mechanical ventilator, intensive care unit (ICU) stay, and 28-day mortality rate were analyzed.Results The incidence of sepsis-associated encephalopathy was 17.7%. The sepsis-associated encephalopathy group had significantly higher 28-day mortality (56.1% vs. 35.1%; P=0.013), spent a significantly longer time on a ventilator ((8.2 +/- 2.2) days vs. (2.9 +/- 0.4) days; P=0.021), and had a significantly longer ICU stay ((12.4 +/- 2.4) days vs. (7.1 +/- 0.6) days; P=0.042). Acute physiology and chronic health evaluation II score, Glasgow coma scale, heart rate, blood lactate, serum sodium, platelets, serum albumin, and pH values were related to the presence of encephalopathy. Patients with biliary tract infections and intestinal infections caused by Staphylococcus aureus, Enterococcus faecium, Acinetobacter spp, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia, were more prone to develop sepsis-associated encephalopathy.Conclusions Encephalopathy increases mortality rate in septic patients. Clinical intervention to reduce risk factors and thereby morbidity and mortality depends on a correct understanding of the differences between patients with sepsis and patients with both sepsis and encephalopathy. Chin Med J 2012;125(5):828-831

Progress in Research of Pathogenesis of Septic Encephalopathy

Research progress in the pathogenesis of sepsis-associated encephalopathy

Pathogenesis of sepsis-associated encephalopathy: more than blood–brain barrier dysfunction

The Advance of Pathogenesis of Sepsis-Associated Encephalopathy

Diagnosis and Pathophysiology of Septic-Associated Encephalopathy

Basic research and clinical progress of sepsis-associated encephalopathy

Research progress on the role of mitochondrial quality control in sepsis associated encephalopathy

Rearch Progress in Pathogenesis of Sepsis

Review on the Role of Mitochondrial Dysfunction in Septic Encephalopathy

[Research progress on the changes of blood-brain barrier in sepsis-associated encephalopathy]

[Research progress on the role of microglia in sepsis-associated encephalopathy]

Septic encephalopathy:diagnosis faces confusion

The role of the peripheral system dysfunction in the pathogenesis of sepsis-associated encephalopathy

Clinical Analysis of Epidemiological Characteristics and Risk Factors of Septic Encephalopathy

Research Progress of Biomarkers of Sepsis-Associated Encephalopathy

Sepsis-Associated Encephalopathy: from Pathophysiology to Progress in Experimental Studies

Neuroimmune Regulation in Sepsis-Associated Encephalopathy: The Interaction Between the Brain and Peripheral Immunity

Epidemiological Features and Risk Factors of Sepsis-Associated Encephalopathy in Intensive Care Unit Patients: 2008-2011.

ROLE OF MICROGLIA IN SEPSIS-ASSOCIATED ENCEPHALOPATHY PATHOGENESIS: AN UPDATE

Paediatric sepsis-associated encephalopathy (SAE): a comprehensive review

The biological alterations of synapse/synapse formation in sepsis-associated encephalopathy